AnalystsDavid Nierengarten
David Nierengarten's Stock Forecasts

Analyst Ranking
Top 6%
#316 out of 5561 analysts
Average Return
+10%
Win Rate
45%142 out of 315
Risk vs Reward
Poor
Good

David Nierengarten's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Chimerix IncCMRX
+870.45%$0.88$8.54
2024-11-18 -
2025-04-17
Buy
Anaptysbio IncANAB
+405.93%$23.10$116.87
2017-03-09 -
2018-03-09
Buy
Fusion Pharmaceuticals IncFUSN
+382.46%$4.39$21.18
2023-06-28 -
2024-03-19
Buy
G1 Therapeutics IncGTHX
+352.53%$1.58$7.15
2023-10-30 -
2024-09-17
Buy
Beam Therapeutics IncBEAM
+300.96%$23.02$92.30
2020-03-02 -
2021-03-02
Buy

David Nierengarten Analyst Color

Get additional color on David Nierengarten's coverage of popular stocks

David Nierengarten's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Bridgebio Oncology Therapeutics IncBBOT
4Buy$9.00+354.55%Maintains
6 days ago
Beam Therapeutics IncBEAM
9Buy$33.00+57.59%Maintains
6 days ago
Novocure LtdNVCR
9Hold$19.00+68.14%Maintains
7 days ago
Perspective Therapeutics IncCATX
10Buy$7.00+657.58%Maintains
7 days ago
Spyre Therapeutics IncSYRE
6Buy$120.00+20.76%Maintains
13 days ago
Bicara Therapeutics IncBCAX
6Buy$24.00+146.15%Maintains
19 days ago
Kiniksa Pharmaceuticals International PLCKNSA
11Buy$102.00+8.25%Maintains
20 days ago
Artiva Biotherapeutics IncARTV
2Hold$4.00+1.01%Downgrades
21 days ago
Oric Pharmaceuticals IncORIC
12Buy$14.00+86.17%Maintains
21 days ago
Immunome IncIMNM
11Buy$35.00+98.75%Reiterates
21 days ago
Xencor IncXNCR
12Buy$45.00+27.12%Maintains
21 days ago
Telix Pharmaceuticals LtdTLX
10Buy$22.00+146.64%Reiterates
a month ago
Abivax SaABVX
5Hold$96.00+14.82%Maintains
a month ago
Disc Medicine IncIRON
9Buy$110.00+43.62%Maintains
a month ago
Sutro Biopharma IncSTRO
10Buy$60.00+543.78%Reiterates
a month ago
Aktis Oncology IncAKTS
2Buy$35.00+116.58%Reiterates
2 months ago
Shattuck Labs IncSTTK
4Buy$14.00+200.43%Maintains
2 months ago
Damora Therapeutics IncDMRA
4Buy$40.00+77.82%Reiterates
2 months ago
Nuvation Bio IncNUVB
18Buy$11.00+186.46%Reiterates
2 months ago
Cogent Biosciences IncCOGT
7Buy$55.00+100.44%Reiterates
2 months ago
Scholar Rock Holding CorpSRRK
12Buy$70.00+57.16%Maintains
2 months ago
Intellia Therapeutics IncNTLA
12Hold$13.00+31.85%Maintains
2 months ago
Argenx SeARGX
30Buy$1,150.00+20.93%Reiterates
2 months ago
Tscan Therapeutics IncTCRX
7Hold$1.00+589.66%Downgrades
2 months ago
Hemab Therapeutics Holdings IncCOAG
2Buy$64.00+63.87%Maintains
3 months ago
Fennec Pharmaceuticals IncFENC
5Buy$16.00+25.39%Maintains
3 months ago
Apogee Therapeutics IncAPGE
6Hold$135.00-0.05%Downgrades
5 months ago
Nuvalent IncNUVL
10Hold$124.00+0.03%Downgrades
5 months ago
Odyssey Therapeutics IncODTX
1Buy$30.00+54.96%Initiates Coverage On
5 months ago
Generation Bio CoGBIO
10Buy$5.50+3.00%Upgrades
a year ago
Fate Therapeutics IncFATE
14Buy$7.00N/AUpgrades
a year ago
Imagenebio IncIMA
5Hold$276.00N/AMaintains
a year ago
Vor Biopharma IncVOR
7Hold$8.00N/AReiterates
a year ago
Blueprint Medicines CorpBPMC
5Hold$129.00N/ADowngrades
a year ago
Iteos Therapeutics IncITOS
3Hold$12.00N/ADowngrades
a year ago
Springworks Therapeutics IncSWTX
3Buy$77.00N/AReiterates
2 years ago
Anaptysbio IncANAB
12Buy$40.00N/AMaintains
2 years ago
Chimerix IncCMRX
3Buy$6.00N/AReiterates
2 years ago
Inozyme Pharma IncINZY
6Buy$15.00N/AReiterates
2 years ago
Y Mabs Therapeutics IncYMAB
3Buy$23.00N/AReiterates
2 years ago
Oruka Therapeutics IncORKA
1Buy$40.00N/AInitiates Coverage On
2 years ago
2seventy Bio IncTSVT
8Hold$5.00N/AReiterates
2 years ago
Prime Medicine IncPRME
3Buy$12.00N/AReiterates
3 years ago
Fusion Pharmaceuticals IncFUSN
4Hold$24.00N/ADowngrades
3 years ago
Bluebird Bio IncBLUE
1Hold$33.60N/AMaintains
3 years ago
Mersana Therapeutics IncMRSN
2Buy$175.00N/AUpgrades
3 years ago
G1 Therapeutics IncGTHX
6Buy$4.00N/AMaintains
3 years ago
Kinnate Biopharma IncKNTE
4Hold$2.00N/AReiterates
3 years ago
Maxeon Solar Technologies LtdMAXNQ
1Hold$500.00N/AMaintains
3 years ago
Freeline Therapeutics Holdings PLCFRLN
2Hold$5.00N/ADowngrades
3 years ago
Karyopharm Therapeutics IncKPTI
7Hold$60.00N/AMaintains
3 years ago
Theseus Pharmaceuticals IncTHRX
2Buy$7.00N/AMaintains
3 years ago
Tectonic Therapeutic IncTECX
1Hold$24.00N/ADowngrades
3 years ago
Iveric Bio IncISEE
3Hold$40.00N/ADowngrades
4 years ago
Applied Genetic Technologies CorpAGTC
1HoldN/AN/ADowngrades
4 years ago
Epizyme IncEPZM
1HoldN/AN/ADowngrades
4 years ago
Turning Point Therapeutics IncTPTX
1Hold$76.00N/ADowngrades
4 years ago
Codiak Biosciences IncCDAKQ
1Buy$24.00N/AMaintains
5 years ago
Tcr2 Therapeutics IncTCRR
1Hold$11.00N/ADowngrades
5 years ago
Myokardia IncMYOK
1Hold$225.00N/ADowngrades
6 years ago
Stemline Therapeutics IncSTML
3Hold$12.50N/ADowngrades
7 years ago
Syros Pharmaceuticals IncSYRS
3Hold$90.00N/ADowngrades
7 years ago
Tesaro IncTSRO
3Hold$75.00N/ADowngrades
8 years ago
Spark Therapeutics IncONCE
2Hold$40.00N/AUpgrades
8 years ago
Ultragenyx Pharmaceutical IncRARE
6Buy$88.00N/AMaintains
8 years ago
Audentes Therapeutics IncBOLD1
1Buy$52.00N/AMaintains
8 years ago
Endocyte IncECYT
3Buy$21.00N/AMaintains
8 years ago
Voyager Therapeutics IncVYGR
2BuyN/AN/AUpgrades
9 years ago
Prothena Corp Public Ltd CoPRTA
1HoldN/AN/ADowngrades
9 years ago
Kite Pharma IncKITE
2HoldN/AN/AUpgrades
9 years ago
Juno Therapeutics IncJUNO
1BuyN/AN/AUpgrades
9 years ago
Clementia Pharmaceuticals IncCMTA
1Buy$26.00N/AInitiates Coverage On
9 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.